The European Voice of the Patient living with pulmonary hypertension associated with interstitial lung disease: Diagnosis, symptoms, impacts, and treatments

Documenti analoghi

• Screening and diagnosis of pulmonary hypertension associated with chronic lung disease (PH‐CLD): A consensus statement from the pulmonary vascular research institute's innovative drug development initiative—group 3 pulmonary hypertension
  di: P. Vitulo, et al.
  Pubblicazione: (2024)
• Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension
  di: Oksana A. Shlobin, et al.
  Pubblicazione: (2024)
• Pulmonary vascular disease, environmental pollution, and climate change
  di: Mona Lichtblau, et al.
  Pubblicazione: (2024)
• Severe pulmonary hypertension due to combined pulmonary fibrosis and emphysema: another cause of death among smokers
  di: André Carramenha de Góes Hirano
  Pubblicazione: (2017)
• Predictors of early mortality after lung transplantation for idiopathic pulmonary arterial hypertension
  di: Reda E. Girgis, et al.
  Pubblicazione: (2024)